Read the Full Press Release > Here
ICIG’s CordenPharma Group today announced the closing of a syndicated loan of EUR 60 Million.
CordenPharma successfully closed its first syndicated loan on advantageous terms. The amount of EUR 60 Million is split into a term loan and revolving credit facility with the option of a further increase. Funds could be used for general corporate purposes and acquisitions. The facilities create a solid basis to achieve the growth plans of the group. The inaugural financing was co-ordinated by ING Bank in a syndicate that also includes Bayerische Landesbank and Intesa Sanpaolo.